US Bancorp’s Alpine Immune Sciences Inc ALPN Stock Holding History

US Bancorp’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,240	Closed	-$128K	–	4144
2024 Q1	$128K	Buy	+3,240	New	+$95.6K	﹤0.01%	2232

US Bancorp's ALPN Position: Q2 2024 in Review

US Bancorp sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 3,240 shares — an estimated $128K sold.

US Bancorp first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $128K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

US Bancorp reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
US Bancorp sold 3,240 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $128K.
US Bancorp first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
US Bancorp's Alpine Immune Sciences Inc position peaked at $128K in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on US Bancorp's 13F filing for Q2 2024, filed 7 Aug 2024.